Literature DB >> 3265862

Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography.

N L Foster1, S Gilman, S Berent, E M Morin, M B Brown, R A Koeppe.   

Abstract

Progressive supranuclear palsy (PSP) is characterized by supranuclear palsy of gaze, axial dystonia, bradykinesia, rigidity, and a progressive dementia. Pathological changes in this disorder are generally restricted to subcortical structures, yet the type and range of cognitive deficits suggest the involvement of many cerebral regions. We examined the extent of functional impairment to cerebral cortical and subcortical structures as measured by the level of glucose metabolic activity at rest. Fourteen patients with PSP were compared to 21 normal volunteers of similar age using 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography. Glucose metabolism was reduced in the caudate nucleus, putamen, thalamus, pons, and cerebral cortex, but not in the cerebellum in the patients with PSP as compared to the normal subjects. Analysis of individual brain regions revealed significant declines in cerebral glucose utilization in most regions throughout the cerebral cortex, particularly those in the superior half of the frontal lobe. Declines in the most affected regions of cerebral cortex were greater than those in any single subcortical structure. Although using conventional neuropathological techniques the cerebral cortex appears to be unaffected in PSP, significant and pervasive functional impairments in both cortical and subcortical structures are present. These observations help to account for the constellation of cognitive symptoms in individual patients with PSP and the difficulty encountered in identifying a characteristic psychometric profile for this group of patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265862     DOI: 10.1002/ana.410240308

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  30 in total

Review 1.  PET and movement disorders.

Authors:  D J Brooks; R S Frackowiak
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

2.  Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.

Authors:  H Karbe; M Grond; M Huber; K Herholz; J Kessler; W D Heiss
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

Review 3.  PET: its clinical role in neurology.

Authors:  D Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

Review 4.  The neurodegenerative mitochondriopathies.

Authors:  Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 5.  PET/CT in diagnosis of movement disorders.

Authors:  Valentina Berti; Alberto Pupi; Lisa Mosconi
Journal:  Ann N Y Acad Sci       Date:  2011-06       Impact factor: 5.691

6.  A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism (Niccolini and Politis, 2016) : Reply to Jean-Claude Baron Letter to Editor.

Authors:  Marios Politis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-03       Impact factor: 9.236

7.  A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism.

Authors:  Jean-Claude Baron
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-15       Impact factor: 9.236

8.  Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease.

Authors:  Andrea Varrone; Marco Pagani; Elena Salvatore; Dario Salmaso; Valeria Sansone; Marianna Amboni; Flavio Nobili; Giuseppe De Michele; Alessandro Filla; Paolo Barone; Sabina Pappatà; Marco Salvatore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-24       Impact factor: 9.236

9.  Intrinsic connectivity network disruption in progressive supranuclear palsy.

Authors:  Raquel C Gardner; Adam L Boxer; Andrew Trujillo; Jacob B Mirsky; Christine C Guo; Efstathios D Gennatas; Hilary W Heuer; Eric Fine; Juan Zhou; Joel H Kramer; Bruce L Miller; William W Seeley
Journal:  Ann Neurol       Date:  2013-03-27       Impact factor: 10.422

10.  Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities.

Authors:  N L Foster; S Gilman; S Berent; A A Sima; C D'Amato; R A Koeppe; S P Hicks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.